All lobbying filings

CENTER FOR INQUIRY, INC. OFFICE OF PUBLIC POLICY

Lobbying for CENTER FOR INQUIRY, INC. OFFICE OF PUBLIC POLICY · nonprofit organization

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New York

Official filing document

Lobbyists on this filing 1

AZHAR MAJEED

Previously held: Director of Government Affairs and Policy

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 7050
Homeopathic Drug Product Safety, Quality, and Transparency Act

Lobbying activity 1

Science/Technology

CFI's Office of Public Policy lobbied against HR 7050, the "Homeopathic Drug Product Safety, Quality, and Transparency Act." This legislation would allow lax federal regulation of the homeopathy industry, using homeopathy-specific standards set by the industry for safety and efficacy. While homeopathy groups favor this approach, evidence shows that these products are not safe for American consumers and patients. The Office of Public Policy continues to raise awareness among Congressional offices regarding this public health issue.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.